Personalised prophylaxis with simoctocog alfa versus standard emicizumab prophylaxis in haemophilia A, a matching-adjusted indirect comparison

被引：0
|
作者：
Kessler, C. M. [1 ]
Corrales-Medina, F. F. [2 ,3 ]
MannuccioMannucci, P. [4 ]
Astermark, J. [5 ,6 ]
Tarantino, M. D. [7 ]
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC USA
[2] Univ Miami, Div Pediat Hematol Oncol, Dept Pediat, Miller Sch Med, Miami, FL USA
[3] Univ Miami, Hemophilia Treatment Ctr, Miami, FL USA
[4] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[5] Lund Univ, Dept Translat Med, Malmo, Sweden
[6] Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Malmo, Sweden
[7] Bleeding & Clotting Disorders Inst, Peoria, IL USA
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO042
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Relative efficacy of adalimumab versus secukinumab in active psoriatic arthritis: A matching-adjusted indirect comparison
    Betts, Keith
    Mittal, Manish
    Joshi, Avani
    Song, Jinlin
    Bao, Yanjun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB267 - AB267
  • [32] Matching-adjusted indirect comparison of acalabrutinib versus ibrutinib in relapsed/refractory mantle cell lymphoma
    Cai, Ling
    Roos, Jack
    Miranda, Paulo A. P.
    Liljas, Bengt
    Rule, Simon
    Wang, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1552 - 1557
  • [33] Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC
    Castro, Elena
    Wang, Di
    Walsh, Sarah
    Craigie, Samantha
    Haltner, Anja
    Nazari, Jonathan
    Niyazov, Alexander
    Samjoo, Imtiaz A.
    FUTURE ONCOLOGY, 2025,
  • [34] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Vibeke Strand
    Keith A. Betts
    Manish Mittal
    Jinlin Song
    Martha Skup
    Avani Joshi
    Rheumatology and Therapy, 2017, 4 : 349 - 362
  • [35] Relative Efficacy of Adalimumab Versus Secukinumab in Active Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Betts, Keith A.
    Mittal, Manish
    Joshi, Avani
    Song, Jinlin
    Bao, Yanjun
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): SENSITIVITY ANALYSES AND GRAPHICAL DIAGNOSTICS
    Signorovitch, J.
    Cao, W.
    Rybkin, V
    Yao, Z.
    Hellstern, M.
    VALUE IN HEALTH, 2017, 20 (09) : A771 - A771
  • [37] Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison
    Phillippo, David M.
    Dias, Sofia
    Ades, A. E.
    Welton, Nicky J.
    RESEARCH SYNTHESIS METHODS, 2020, 11 (04) : 568 - 572
  • [38] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Choy, Ernest H.
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
    Armstrong, April W.
    Soliman, Ahmed M.
    Gisondi, Paolo
    Fang, Siran
    Patel, Manish
    Strober, Bruce
    DERMATOLOGY AND THERAPY, 2024, 14 (11) : 3071 - 3081
  • [40] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison
    Strand, Vibeke
    Mease, Philip J.
    McInnes, Iain B.
    Nash, Peter
    Thom, Howard
    Hunger, Matthias
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345